In another clinical trial, exosomes from the ascites of colorectal cancer (CRC) patients in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), rather than ascite-derived exosomes (Aex) alone, induced antigen-specific T-cell response [80]. Here, CSF2 is linked to colorectal cancer.